POSITRON EMISSION TOMOGRAPHY IMAGING OF PHOSPHODIESTERASE 10 A ENZYME AND DOPAMINE D2 RECEPTOR IN HUNTINGTON'S DISEASE GENE EXPANSION CARRIERS

被引：1
|
作者：
Fazio, P. [1 ]
Fitzer-Attas, C. [2 ]
Mrzljak, L. [2 ]
Martinsson, S. [1 ]
Landwehrmeyer, G. B. [2 ]
Bronzova, J.
Al-Tawil, N. [3 ]
Halldin, C. [1 ]
Sampaio, C. [2 ]
Varrone, A. [1 ]
机构：
[1] Karolinska Inst, Dept Clin Neurosci, Ctr Psychiat Res, Stockholm, Sweden
[2] CHDI Fdn, Princeton, NJ USA
[3] Karolinska Univ Hosp, Karolinska Trial Alliance, Huddinge, Sweden
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2014年 / 85卷
关键词：
D O I：
10.1136/jnnp-2014-309032.134
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
E31
引用
收藏
页码：A47 / A47
页数：1
相关论文
共 50 条
  • [1] Imaging of phosphodiesterase 10A (PDE10A) enzyme and D2 receptor levels in the living brain of Huntington's disease gene expansion carriers and healthy controls
    Fitzer-Attas, C.
    Fazio, P.
    Mrzljak, L.
    Martinsson, S.
    Landwehrmeyer, B.
    Bronzova, J.
    Al-Tawil, N.
    Halldin, C.
    Sampaio, C.
    Varrone, A.
    MOVEMENT DISORDERS, 2014, 29 (14) : 1843 - 1843
  • [2] Imaging of phosphodiesterase 10A (PDE10A) enzyme and D2 receptor levels in the living brain of Huntington's disease gene expansion carriers and healthy controls
    Fitzer-Attas, C.
    Fazio, P.
    Mrzljak, L.
    Martinsson, S.
    Landwehr-Meyer, B.
    Bronzova, J.
    Al-Tawil, N.
    Halldin, C.
    Sampaio, C.
    Varrone, A.
    MOVEMENT DISORDERS, 2014, 29 : S207 - S208
  • [3] Imaging of phosphodiesterase 10 A (PDE10A) enzyme levels in the living human brain of Huntington's disease gene expansion carriers and healthy controls with positron emission tomography.
    Fazio, P.
    Fittzer-Attas, C.
    Bronzova, J.
    Nag, S.
    Warner, J.
    Landwehrmeyer, B.
    Al-Tawil, N.
    Halldin, C.
    Mrzljak, L.
    Sampaio, C.
    Varrone, A.
    MOVEMENT DISORDERS, 2017, 32
  • [4] Cortical dopamine D2 receptor availability in symptomatic and asymptomatic Huntington's disease gene carriers
    Pavese, Nicola
    Tai, Yen F.
    Barker, Roger
    Mason, Sarah
    Brooks, David J.
    Piccini, Paola
    NEUROLOGY, 2007, 68 (12) : A364 - A365
  • [5] Positron emission tomography imaging of dopamine D2 receptors using a highly selective radiolabeled D2 receptor partial agonist
    Xu, Jinbin
    Vangveravong, Suwanna
    Li, Shihong
    Fan, Jinda
    Jones, Lynne A.
    Cui, Jinquan
    Wang, Ruike
    Tu, Zhude
    Chu, Wenhua
    Perlmutter, Joel S.
    Mach, Robert H.
    NEUROIMAGE, 2013, 71 : 168 - 174
  • [6] Cortical dopamine D2 receptor dysfunction in Huntington's disease
    Pavese, N
    Rosser, AE
    Brooks, DJ
    Barker, RA
    Dunnett, SB
    Piccini, P
    MOVEMENT DISORDERS, 2002, 17 : S318 - S318
  • [7] Extrastriatal Dopamine D2 Receptor Binding in Huntington's Disease
    Esmaeilzadeh, Mouna
    Farde, Lars
    Karlsson, Per
    Varrone, Andrea
    Halldin, Christer
    Waters, Susanna
    Tedroff, Joakim
    HUMAN BRAIN MAPPING, 2011, 32 (10) : 1626 - 1636
  • [8] Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease
    Weeks, RA
    Piccini, P
    Harding, AE
    Brooks, DJ
    ANNALS OF NEUROLOGY, 1996, 40 (01) : 49 - 54
  • [9] The impact of stereotactic pallidal surgery on the dopamine D2 receptor in Parkinson disease:: a positron emission tomography study
    Nakajima, T
    Nimura, T
    Yamaguchi, K
    Ando, T
    Itoh, M
    Yoshimoto, T
    Shirane, R
    JOURNAL OF NEUROSURGERY, 2003, 98 (01) : 57 - 63
  • [10] Development of high affinity, highly selective agonist ligands for positron emission tomography imaging of the dopamine D2 receptor
    Sromek, Anna W.
    Neumeyer, John L.
    Si, Yu-Gui
    Zhang, Tangzhi
    Seeman, Philip
    George, Susan R.
    Farde, Lars
    Halldin, Christer
    Stepanov, Vladimir
    Finnema, Sjoerd
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
12345